Unsoy Gozde, Khodadust Rouhollah, Yalcin Serap, Mutlu Pelin, Gunduz Ufuk
Middle East Technical University, Department of Biotechnology, 06800 Ankara, Turkey.
Middle East Technical University, Department of Biotechnology, 06800 Ankara, Turkey.
Eur J Pharm Sci. 2014 Oct 1;62:243-50. doi: 10.1016/j.ejps.2014.05.021. Epub 2014 Jun 12.
Targeted drug delivery is a promising alternative to overcome the limitations of classical chemotherapy. In an ideal targeted drug delivery system carrier nanoparticles would be directed to the tumor tissue and selectively release therapeutic molecules. As a novel approach, chitosan coated magnetic nanoparticles (CS MNPs) maintain a pH dependent drug delivery which provides targeting of drugs to the tumor site under a magnetic field. Among various materials, chitosan has a great importance as a pH sensitive, natural, biodegradable, biocompatible and bioadhesive polymer. The aim of this study was to obtain an effective targeted delivery system for Doxorubicin, using chitosan coated MNPs. Different sized CS MNPs were produced by in situ synthesis method. The anti-cancer agent Doxorubicin was loaded onto CS MNPs which were characterized previously. Doxorubicin loading was confirmed by FTIR. Drug loading and release characteristics, and stability of the nanoparticles were investigated. Our results showed that the CS MNPs have pH responsive release characteristics. The cellular internalization of Doxorubicin loaded CS MNPs were visualized by fluorescent microscopy. Doxorubicin loaded CS MNPs are efficiently taken up by MCF-7 (MCF-7/S) and Doxorubicin resistant MCF-7 (MCF-7/1 μM) breast cancer cells, which increases the efficacy of drug and also maintains overcoming the resistance of Doxorubicin in MCF-7/Dox cells. Consequently, CS MNPs synthesized at various sizes can be effectively used for the pH dependent release of Doxorubicin in cancer cells. Results of this study can provide new insights in the development of pH responsive targeted drug delivery systems to overcome the side effects of conventional chemotherapy.
靶向给药是克服传统化疗局限性的一种有前景的替代方法。在理想的靶向给药系统中,载体纳米颗粒会被导向肿瘤组织并选择性地释放治疗分子。作为一种新方法,壳聚糖包被的磁性纳米颗粒(CS MNPs)维持pH依赖性药物递送,可在磁场作用下将药物靶向递送至肿瘤部位。在各种材料中,壳聚糖作为一种pH敏感、天然、可生物降解、生物相容且具有生物粘附性的聚合物具有重要意义。本研究的目的是利用壳聚糖包被的MNPs获得一种有效的阿霉素靶向递送系统。通过原位合成法制备了不同尺寸的CS MNPs。将抗癌药物阿霉素负载到先前已表征的CS MNPs上。通过傅里叶变换红外光谱(FTIR)证实了阿霉素的负载。研究了纳米颗粒的载药和释药特性以及稳定性。我们的结果表明CS MNPs具有pH响应释放特性。通过荧光显微镜观察了负载阿霉素的CS MNPs的细胞内化情况。负载阿霉素的CS MNPs能被MCF-7(MCF-7/S)和阿霉素耐药的MCF-7(MCF-7/1 μM)乳腺癌细胞有效摄取,这提高了药物疗效,同时也能克服MCF-7/Dox细胞对阿霉素的耐药性。因此,不同尺寸合成的CS MNPs可有效地用于癌细胞中阿霉素的pH依赖性释放。本研究结果可为开发pH响应性靶向给药系统以克服传统化疗的副作用提供新的见解。